These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 12882872)
1. APOE polymorphism and the progression of diabetic nephropathy in Japanese subjects with type 2 diabetes: results of a prospective observational follow-up study. Araki S; Koya D; Makiishi T; Sugimoto T; Isono M; Kikkawa R; Kashiwagi A; Haneda M Diabetes Care; 2003 Aug; 26(8):2416-20. PubMed ID: 12882872 [TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E genetic polymorphism influence the susceptibility to nephropathy in type 2 diabetes patients. Atageldiyeva KK; Nemr R; Echtay A; Racoubian E; Sarray S; Almawi WY Gene; 2019 Oct; 715():144011. PubMed ID: 31357022 [TBL] [Abstract][Full Text] [Related]
3. ε2 allele and ε2-involved genotypes (ε2/ε2, ε2/ε3, and ε2/ε4) may confer the association of APOE genetic polymorphism with risks of nephropathy in type 2 diabetes: a meta-analysis. Shi J; Cheng Z; Qiu S; Cui H; Gu Y; Zhao Q; Ren Y; Zhang H; Sun H; Liu Y; Li Y; Qiao Y; Hu Y; Liu Y; Cheng Y Lipids Health Dis; 2020 Jun; 19(1):136. PubMed ID: 32534589 [TBL] [Abstract][Full Text] [Related]
4. Association between apolipoprotein E polymorphism and nephropathy in Iranian diabetic patients. Karimoei M; Pasalar P; Mehrabzadeh M; Daneshpour M; Shojaee M; Forouzanfar K; Razi F Saudi J Kidney Dis Transpl; 2017; 28(5):997-1002. PubMed ID: 28937055 [TBL] [Abstract][Full Text] [Related]
5. The relationship of the apolipoprotein E gene polymorphism Turkish Type 2 diabetic patients with and without nephropathy. Erdogan M; Eroglu Z; Biray C; Karadeniz M; Cetinkalp S; Kosova B; Gunduz C; Topcuoglu N; Ozgen G; Yilmaz C J Endocrinol Invest; 2009 Mar; 32(3):219-22. PubMed ID: 19542737 [TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E polymorphism and expression in type 2 diabetic patients with nephropathy: clinicopathological correlation. Guan J; Zhao HL; Baum L; Sui Y; He L; Wong H; Lai FM; Tong PC; Chan JC Nephrol Dial Transplant; 2009 Jun; 24(6):1889-95. PubMed ID: 19218599 [TBL] [Abstract][Full Text] [Related]
8. Age-dependent association of apolipoprotein E genotypes with stroke subtypes in a Japanese rural population. Kokubo Y; Chowdhury AH; Date C; Yokoyama T; Sobue H; Tanaka H Stroke; 2000 Jun; 31(6):1299-306. PubMed ID: 10835448 [TBL] [Abstract][Full Text] [Related]
9. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients. Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519 [TBL] [Abstract][Full Text] [Related]
10. Higher frequency of apolipoprotein E2 allele in type 2 diabetic patients with nephropathy in Taiwan. Hsieh MC; Lin SR; Yang YC; Chen HC; Lin JN; Shin SJ J Nephrol; 2002; 15(4):368-73. PubMed ID: 12243365 [TBL] [Abstract][Full Text] [Related]
11. Co-inheritance of specific genotypes of HSPG and ApoE gene increases risk of type 2 diabetic nephropathy. Liu L; Xiang K; Zheng T; Zhang R; Li M; Li J Mol Cell Biochem; 2003 Dec; 254(1-2):353-8. PubMed ID: 14674716 [TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM. Kimura H; Suzuki Y; Gejyo F; Karasawa R; Miyazaki R; Suzuki S; Arakawa M Am J Kidney Dis; 1998 Apr; 31(4):666-73. PubMed ID: 9531184 [TBL] [Abstract][Full Text] [Related]
13. Type 2 diabetes mellitus and its renal complications in relation to apolipoprotein E gene polymorphism. Ma SW; Benzie IF; Yeung VT Transl Res; 2008 Sep; 152(3):134-42. PubMed ID: 18774543 [TBL] [Abstract][Full Text] [Related]
14. Association between apolipoprotein E genetic polymorphism and the development of diabetic nephropathy in type 2 diabetic patients. Kwon MK; Rhee SY; Chon S; Oh S; Woo JT; Kim SW; Kim JW; Kim YS; Jeong KH; Lee SH; Lee TW; Ihm CG Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S228-32. PubMed ID: 17624465 [TBL] [Abstract][Full Text] [Related]
15. Influence of apolipoprotein E genotype on progression of diabetic nephropathy. Joss N; Jardine A; Gaffney D; Boulton-Jones JM Nephron Exp Nephrol; 2005; 101(4):e127-33. PubMed ID: 16113584 [TBL] [Abstract][Full Text] [Related]
17. APOE polymorphisms and the development of diabetic nephropathy in type 1 diabetes: results of case-control and family-based studies. Araki S; Moczulski DK; Hanna L; Scott LJ; Warram JH; Krolewski AS Diabetes; 2000 Dec; 49(12):2190-5. PubMed ID: 11118024 [TBL] [Abstract][Full Text] [Related]
18. [Polymorphic gene markers of lipid metabolism are associated with diabetic nephropathy in patients with type 1 diabetes mellitus]. Iakunina NIu; Shestakova MV; Voron'ko OE; Vikulova OK; Sevost'ianov KV; Chugunova LA; Shamkhalova MSh; Dedov II; Nosikov VV Genetika; 2005 Jul; 41(7):931-7. PubMed ID: 16152798 [TBL] [Abstract][Full Text] [Related]
19. Comparative study of apolipoprotein-E polymorphism and plasma lipid levels in dyslipidemic and asymptomatic subjects, and their implication in cardio/cerebro-vascular disorders. Ferreira CN; Carvalho MG; Fernandes AP; Lima LM; Loures-Valle AA; Dantas J; Janka Z; Palotás A; Sousa MO Neurochem Int; 2010 Jan; 56(1):177-82. PubMed ID: 19819279 [TBL] [Abstract][Full Text] [Related]
20. Apo E gene polymorphism on development of diabetic nephropathy. Ilhan N; Kahraman N; Seçkin D; Ilhan N; Colak R Cell Biochem Funct; 2007; 25(5):527-32. PubMed ID: 16933203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]